RECRUITING

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Talk to us

Conditions

Non-small Cell Lung Cancer

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This trial will evaluate the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated NSCLC tumors that meet protocol-specified biomarker criteria.

Official Title

NAUTIKA1: A Multicenter, Phase II, Neoadjuvant and Adjuvant Study of Multiple Therapies in Biomarker-selected Patients With Resectable Stages IB-III Non-small Cell Lung Cancer

Quick Facts

Study Start:2020-11-06
Study Completion:2030-05-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04302025

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Reference Study ID Number: ML41591 https://forpatients.roche.com/
CONTACT
888-662-6728
global-roche-genentech-trials@gene.com

Principal Investigator

Clinical Trials
STUDY_DIRECTOR
Hoffmann-La Roche

Study Locations (Sites)

City of Hope Comprehensive Cancer Center
Duarte, California, 91010
United States
City of Hope - Orange County Lennar Foundation Cancer Center
Irvine, California, 92618
United States
USC Norris Cancer Center
Los Angeles, California, 90033
United States
Cedars-Sinai Medical Center
Los Angeles, California, 90048
United States
University of California Los Angeles - Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095
United States
The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange
Orange, California, 92868
United States
UC Davis Comprehensive Cancer Center
Sacramento, California, 95817
United States
UCSF Helen Diller Family CCC
San Francisco, California, 94158
United States
University of Colorado - Anschutz Medical Campus (University of Colorado Health Sciences Center)
Aurora, Colorado, 80045
United States
Yale Cancer Center
New Haven, Connecticut, 06511
United States
MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center)
Washington D.C., District of Columbia, 20007
United States
Moffitt Cancer Center
Tampa, Florida, 33612
United States
Northwestern University
Chicago, Illinois, 60611
United States
Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois, 60115
United States
Northwestern Medicine Cancer Center Delnor
Geneva, Illinois, 60134
United States
Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois, 60555
United States
Boston Medical Center
Boston, Massachusetts, 02118
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
United States
University of Michigan
Ann Arbor, Michigan, 48109
United States
Karmanos Cancer Institute - Farmington Hills/Weisberg Cancer Treatment Center
Farmington Hills, Michigan, 48334
United States
Mayo Clinic
Rochester, Minnesota, 55905
United States
Ellis Fischel Cancer Center
Columbia, Missouri, 65201
United States
Siteman Cancer Center - Washington University Medical Campus
St Louis, Missouri, 63108
United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756
United States
Laura and ISAAC Perlmutter Cancer Center at NYU Langone.
New York, New York, 10016
United States
Columbia University Medical Center
New York, New York, 10032
United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44016
United States
Ohio State University
Columbus, Ohio, 43210
United States
AHN Cancer Institute ? Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212
United States
Baptist Clinical Research Institute
Memphis, Tennessee, 38120
United States
Tennessee Oncology - Nashville
Nashville, Tennessee, 37203
United States
Kelsey Seybold Clnic
Houston, Texas, 77025
United States
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030-4008
United States
Baylor College of Medicine
Houston, Texas, 77030
United States
Lumi Research
Kingwood, Texas, 77339
United States
Virginia Cancer Specialists (Fairfax) - USOR
Fairfax, Virginia, 22031
United States
Seattle Cancer Care Alliance
Seattle, Washington, 98109
United States

Collaborators and Investigators

Sponsor: Genentech, Inc.

  • Clinical Trials, STUDY_DIRECTOR, Hoffmann-La Roche

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-11-06
Study Completion Date2030-05-30

Study Record Updates

Study Start Date2020-11-06
Study Completion Date2030-05-30

Terms related to this study

Additional Relevant MeSH Terms

  • Non-small Cell Lung Cancer